Advertisement

Journal of Neuro-Oncology

, Volume 108, Issue 2, pp 327–332 | Cite as

Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery

  • A. Talacchi
  • D. d’Avella
  • L. Denaro
  • B. Santini
  • P. Meneghelli
  • S. Savazzi
  • M. Gerosa
Effects of Standard of Art Treatment

Abstract

Although validated tools (neuropsychological tests, patient reported outcomes, mood and psychological profile) were first introduced many years ago in clinical practice, the impact of the tumor itself on patient cognition has not been extensively studied. Furthermore, while outcome research is evolving in an attempt to adapt the use of different tools to the preoperative and postoperative phases, the standard guidelines for evaluating outcome after brain surgery, by neurological examination and complication assessment, are frequently neglected in the current literature. This article attempts to provide an appraisal of the evidence for the impact of surgical treatment on cognitive function of brain tumor patients within the context of general outcome.

Keywords

Brain tumors Surgical treatment Clinical assessment Cognitive assessment 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez JP, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulation. An anatomo-functional study. Brain 125:199–214PubMedCrossRefGoogle Scholar
  2. 2.
    Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulation in surgery of low-grade gliomas: a comparative study between two series without (1985–1996) and with (1996–2003) functional mapping in the same situation. J Neurol Neurosurg Psychiatry 76:845–851PubMedCrossRefGoogle Scholar
  3. 3.
    Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30(Suppl 19):10–14PubMedCrossRefGoogle Scholar
  4. 4.
    Compostella A, Tosoni A, Blatt V, Franceschi E, Brandes AA (2007) Prognostic factors for anaplastic astrocytomas. J Neurooncol 81:295–303PubMedCrossRefGoogle Scholar
  5. 5.
    Karnofsky DA, Burcheral JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205Google Scholar
  6. 6.
    Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24:1305–1309PubMedCrossRefGoogle Scholar
  7. 7.
    Mauer ME, Bottomley A, Taphoorn MJ (2008) Evaluating health-related quality of life and symptom burden in brain tumour patients: instruments for use in experimental trials and clinical practice. Curr Opin Neurol 21:745–753PubMedCrossRefGoogle Scholar
  8. 8.
    Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151–1161PubMedCrossRefGoogle Scholar
  9. 9.
    Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139–150PubMedCrossRefGoogle Scholar
  10. 10.
    Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363PubMedCrossRefGoogle Scholar
  11. 11.
    Weitzner MA, Meyers CA, Byrne K (1996) Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg 84:29–34PubMedCrossRefGoogle Scholar
  12. 12.
    Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27PubMedCrossRefGoogle Scholar
  13. 13.
    Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO et al (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181PubMedCrossRefGoogle Scholar
  14. 14.
    Chang S, Vogelbaum M, Lang FF, Haines S, Kunwar S, Chiocca EA, Olivi A, Quinones-Hinojosa A, Parsa A, Warnick R (2007) GNOSIS: guidelines for neuro-oncology: standards for investigational studies—reporting of surgically based therapeutic clinical trials. J Neuroncol 82:211–220CrossRefGoogle Scholar
  15. 15.
    Taphoorn MJ, Heimans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolberg JG, Karim ABM (1992) Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiatry 55:372–376PubMedCrossRefGoogle Scholar
  16. 16.
    Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, Van Den Bent MJ, Mason W, Mirimanoff RO et al (2005) Health related quality of life in patients with glioblastoma: a randomised clinical trial. Lancet Oncol 6:937–944PubMedCrossRefGoogle Scholar
  17. 17.
    Giovagnoli AR, Boiardi A (1994) Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 15:481–488PubMedCrossRefGoogle Scholar
  18. 18.
    Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O’Fallon JR, Morton RF, Kuross SA et al (2001) A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer 92:420–433PubMedCrossRefGoogle Scholar
  19. 19.
    Liu R, Page M, Solheim K, Fox S, Chang SM (2009) Quality of life in adults with brain tumors: current knowledge and future directions. Neuro-oncology 11:330–339PubMedCrossRefGoogle Scholar
  20. 20.
    Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568PubMedCrossRefGoogle Scholar
  21. 21.
    Pålson A, Ek L, Ahlström G, Smita A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65:149–158CrossRefGoogle Scholar
  22. 22.
    Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumors. Lancet Neurol 3:159–168PubMedCrossRefGoogle Scholar
  23. 23.
    World Health Organization (2001) International classification of functioning, disability, and health. World Health Organization, GenevaGoogle Scholar
  24. 24.
    Stummer W, Pichlmaier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392–401PubMedCrossRefGoogle Scholar
  25. 25.
    Phillips C, Guiney M, Smith J, Hughes P, Narayan K, Quong G (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68:23–26PubMedCrossRefGoogle Scholar
  26. 26.
    Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583–1588PubMedCrossRefGoogle Scholar
  27. 27.
    Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535PubMedCrossRefGoogle Scholar
  28. 28.
    Levin VA, Phuphanich S, Yung WK et al (2006) Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. J Neurooncol 78:295–302PubMedCrossRefGoogle Scholar
  29. 29.
    Henriksson R, Malmstrom A, Bergstrom P et al (2006) High-grade astrocytoma treated concomitantly with estramustine and radiotherapy. J Neurooncol 78:321–326PubMedCrossRefGoogle Scholar
  30. 30.
    Souhami L, Seiferheld W, Brachman D et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93–05 protocol. Int J Radiat Oncol Biol Phys 60:853–860PubMedCrossRefGoogle Scholar
  31. 31.
    Cheng J, Zhang X, Liu BL (2009) Health-related quality of life in patients with high-grade glioma. Neuro-oncology 11:41–50PubMedCrossRefGoogle Scholar
  32. 32.
    Efficace F, Bottomley A (2002) Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients. Eur J Cancer 38:1824–1831PubMedCrossRefGoogle Scholar
  33. 33.
    Yung WK, Albright RE, Olson J et al (2000) A phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588–593PubMedCrossRefGoogle Scholar
  34. 34.
    Trojanowski T, Peszynski J, Turowski K et al (1989) Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy. J Neurosurg 70:18–23PubMedCrossRefGoogle Scholar
  35. 35.
    Pickles T, Goodman GB, Rheaume DE et al (1997) Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 37:491–497PubMedCrossRefGoogle Scholar
  36. 36.
    Bampoe J, Laperriere N, Pintilie M, Glen J, Micallef J, Bernstein M (2000) Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment. J Neurosurg 93:917–926PubMedCrossRefGoogle Scholar
  37. 37.
    Kiebert GM, Curran D, Aaronson NK et al (1998) Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 34:1902–1909PubMedCrossRefGoogle Scholar
  38. 38.
    Mintz A, Perry J, Spithoff K, Chambers A, Lapierre N (2007) Management of single brain metastasis: a practice guideline. Curr Oncol 14:131–143PubMedCrossRefGoogle Scholar
  39. 39.
    Signorelli F, Guyotat J, Isnard J, Schneider F, Mohammedi R, Bret P (2001) The value of cortical stimulation applied to the surgery of malignant gliomas in language areas. Neurol Sci 22:3–10PubMedCrossRefGoogle Scholar
  40. 40.
    Fb Meyer, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, Perkins WJ, O’Neill BP (2001) Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76:677–687CrossRefGoogle Scholar
  41. 41.
    Haglund MM, Berger MS, Shamseldin M, Lettich E, Ojemann GA (1994) Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 34:567–576PubMedCrossRefGoogle Scholar
  42. 42.
    Bello L, Gallucci M, Fava M, Carrabba G, Giussani C, Acerbi F, Baratta P, Songa V et al (2007) Intraoperative subcortical language tract mapping guides surgical removal for gliomas involving speech areas. Neurosurgery 60:67–80PubMedCrossRefGoogle Scholar
  43. 43.
    Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Taillandier L, Lopes M, Mitchell MC et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neurosurg 98:764–778PubMedCrossRefGoogle Scholar
  44. 44.
    Medical Research Council (1981) Aids to the examination of the peripheral nervous system. Memorandum no. 45. Her Majesty’s Stationery Office, LondonGoogle Scholar
  45. 45.
    House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147PubMedGoogle Scholar
  46. 46.
    Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55–66PubMedGoogle Scholar
  47. 47.
    Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037–4047PubMedGoogle Scholar
  48. 48.
    Brown PD, Maurer MJ, Rummans TA et al (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495–504PubMedCrossRefGoogle Scholar
  49. 49.
    Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368PubMedCrossRefGoogle Scholar
  50. 50.
    Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr (2004) Depression in patients with high-grade glioma: results of the Glioma Outcome Project. Neurosurgery 54:358–367PubMedCrossRefGoogle Scholar
  51. 51.
    Costello A, Shallice T, Gullan R, Beaney R (2004) The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal brain tumors: the use of a new neuropsychological methodology. J Neurooncol 67:351–359PubMedCrossRefGoogle Scholar
  52. 52.
    Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999PubMedCrossRefGoogle Scholar
  53. 53.
    Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14:1205–1212PubMedCrossRefGoogle Scholar
  54. 54.
    Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333PubMedCrossRefGoogle Scholar
  55. 55.
    Talacchi A, Santini B, Savazzi S, Gerosa M (2010) Cognitive effect of tumor and surgical treatment in glioma patients. J Neuroncol 103:541–549CrossRefGoogle Scholar
  56. 56.
    Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:3129–3140PubMedGoogle Scholar
  57. 57.
    Olson JD, Riedel E, DeAngelis L (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2012

Authors and Affiliations

  • A. Talacchi
    • 1
  • D. d’Avella
    • 3
  • L. Denaro
    • 3
  • B. Santini
    • 1
  • P. Meneghelli
    • 1
  • S. Savazzi
    • 2
  • M. Gerosa
    • 1
  1. 1.Section of Neurosurgery, Department of NeurosciencesUniversity of VeronaVeronaItaly
  2. 2.Section of Physiology, Department of NeurosciencesUniversity of VeronaVeronaItaly
  3. 3.Clinical Neurosurgery, Department of NeurosciencesUniversity of PaduaPaduaItaly

Personalised recommendations